Critically Ill Coronavirus Disease 2019 Patients Exhibit Hyperactive Cytokine Responses Associated With Effector Exhausted Senescent T Cells in Acute Infection.

COVID-19 SARS-CoV-2 exhausted/senescent T cells immunopathology

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
22 11 2021
Historique:
received: 29 04 2021
accepted: 24 08 2021
pubmed: 25 8 2021
medline: 1 10 2022
entrez: 24 8 2021
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) can progress to severe pneumonia with respiratory failure and is aggravated by the deregulation of the immune system causing an excessive inflammation including the cytokine storm. In this study, we report that severe acutely infected patients have high levels of both type-1 and type-2 cytokines. Our results show abnormal cytokine levels upon T-cell stimulation, in a nonpolarized profile. Furthermore, our findings indicate that this hyperactive cytokine response is associated with a significantly increased frequency of late-differentiated T cells with particular phenotype of effector exhausted/senescent CD28-CD57+ cells. Of note, we demonstrated for the first time an increased frequency of CD3+CD4+CD28-CD57+ T cells with expression of programmed death 1, one of the hallmarks of T-cell exhaustion. These findings reveal that COVID-19 is associated with acute immunodeficiency, especially within the CD4+ T-cell compartment, and points to possible mechanisms of loss of clonal repertoire and susceptibility to viral relapse and reinfection events.

Sections du résumé

BACKGROUND
Coronavirus disease 2019 (COVID-19) can progress to severe pneumonia with respiratory failure and is aggravated by the deregulation of the immune system causing an excessive inflammation including the cytokine storm.
METHODS
In this study, we report that severe acutely infected patients have high levels of both type-1 and type-2 cytokines.
RESULTS
Our results show abnormal cytokine levels upon T-cell stimulation, in a nonpolarized profile. Furthermore, our findings indicate that this hyperactive cytokine response is associated with a significantly increased frequency of late-differentiated T cells with particular phenotype of effector exhausted/senescent CD28-CD57+ cells. Of note, we demonstrated for the first time an increased frequency of CD3+CD4+CD28-CD57+ T cells with expression of programmed death 1, one of the hallmarks of T-cell exhaustion.
CONCLUSIONS
These findings reveal that COVID-19 is associated with acute immunodeficiency, especially within the CD4+ T-cell compartment, and points to possible mechanisms of loss of clonal repertoire and susceptibility to viral relapse and reinfection events.

Identifiants

pubmed: 34427670
pii: 6357075
doi: 10.1093/infdis/jiab425
pmc: PMC8513399
doi:

Substances chimiques

CD28 Antigens 0
Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1672-1683

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Angélica Arcanjo (A)

Medical Biochemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Kamila Guimarães Pinto (K)

Microbiology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Jorgete Logullo (J)

Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Paulo Emílio Corrêa Leite (PEC)

Directory of Metrology Applied to Life Sciences - DIMAV, National Institute of Metrology Quality and Technology - INMETRO, Duque de Caxias, Rio de Janeiro, Brazil.

Camilla Cristie Barreto Menezes (CCB)

Tuberculosis Research Laboratory, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Leonardo Freire-de-Lima (L)

Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Israel Diniz-Lima (I)

Veterinary Institute, Federal Rural University of Rio de Janeiro, Rio de Janeiro, Brazil.

Debora Decoté-Ricardo (D)

Veterinary Institute, Federal Rural University of Rio de Janeiro, Rio de Janeiro, Brazil.

Rodrigo Nunes Rodrigues-da-Silva (R)

Laboratory of Monoclonal Antibody Technology, Biomanguinhos, Fiocruz, Rio de Janeiro, Brazil.

Celio Geraldo Freire-de-Lima (C)

Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Alessandra Almeida Filardy (A)

Microbiology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Josué da Costa Lima-Junior (JDC)

Immunoparasitology Laboratory, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.

Alvaro Luiz Bertho (A)

Immunoparasitology Laboratory, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.

Paula Mello De Luca (PM)

Immunoparasitology Laboratory, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.

José Mauro Granjeiro (J)

Directory of Metrology Applied to Life Sciences - DIMAV, National Institute of Metrology Quality and Technology - INMETRO, Duque de Caxias, Rio de Janeiro, Brazil.
Dental School, Fluminense Federal University - UFF, Niteroi, Rio de Janeiro, Brazil.

Shana Priscila Coutinho Barroso (SP)

Molecular Biology Laboratory, Institute of Biomedical Research, Marcílio Dias Naval Hospital, Navy of Brazil, Rio de Janeiro, Brazil.

Fátima Conceição-Silva (F)

Immunoparasitology Laboratory, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.

Wilson Savino (W)

Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
National Institute of Science and Technology on Neuroimmunomodulation - INCT-NIM, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Rio de Janeiro Research Network on Neuroinflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

Alexandre Morrot (A)

Tuberculosis Research Laboratory, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Immunoparasitology Laboratory, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.
Rio de Janeiro Research Network on Neuroinflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH